SLC2A1 and breast carcinoma: In addition, Jia et al. found that miR-143-5p directly targets HIF-1α-related GLUT1 signaling pathway and that highly expressed miR-143-5p can decrease HIF-1α levels and inhibit the expression of GLUT1 in breast cancer cells, thereby controlling the occurrence of breast cancer [30].